142890-84-4

Basic information

• Product Name: 4(1H)-Pyridinone,3-(hydroxymethyl)-(9CI)
• Synonyms: 4(1H)-Pyridinone,3-(hydroxymethyl)-(9CI);3-(Hydroxymethyl)pyridin-4(1H)-one
• CAS NO: 142890-84-4
• Molecular Formula: C₆H₇NO₂
• Molecular Weight: 125.126
• Product Categories: PYRIDINE
• Mol File: 142890-84-4.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 299.895°C at 760 mmHg
• Flash Point: 135.172°C
• Appearance: /
• Density: 1.225g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.538
• PKA: 10.47±0.69(Predicted)
• CAS DataBase Reference: 4(1H)-Pyridinone,3-(hydroxymethyl)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 4(1H)-Pyridinone,3-(hydroxymethyl)-(9CI)(142890-84-4)
• EPA Substance Registry System: 4(1H)-Pyridinone,3-(hydroxymethyl)-(9CI)(142890-84-4)

Safety Data

• Hazardous Substances Data: 142890-84-4(Hazardous Substances Data)

Usage

InChI:InChI=1/C6H7NO2/c8-4-5-3-7-2-1-6(5)9/h1-3,8H,4H2,(H,7,9)

Upstream product

• 89380-70-1 4-hydroxypyridine-3-carboxaldehyde 
• 189449-41-0 4-chloro-3-(hydroxymethyl)pyridine 
• 626-61-9 4-Chloropyridine 
• 114077-82-6 4-chloronicotinaldehyde 

Downstream Products

• 221167-15-3 7-[3-((4-ethoxycarbonylphenylamino)carbonyloxymethyl)-4-pyridon-1-yl]-3,4-dihydro-6-nitro-3-oxoquinoxaline-2-carboxylic acid 
• 221167-14-2 ethyl 3-ethoxy-7-[3-((4-ethoxycarbonylphenylamino)carbonyloxymethyl)-4-pyridon-1-yl]-6-nitroquinoxaline-2-carboxylate 

Relevant articles and documents

Design, synthesis, and AMPA receptor antagonistic activity of a novel 6-nitro-3-oxoquinoxaline-2-carboxylic acid with a substituted phenyl group at the 7 position

We describe the design, synthesis, and biological properties of a novel series of 7-substituted 6-nitro-3-oxoquinoxaline-2-carboxylic acids. After designing, studying the structure-activity relationships, and evaluating the properties of various compounds

6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both

The present invention provides 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid compounds and their addition salts, and processes for preparing them, which have antagonism against excitatory amino acid receptors, in particular, an AMPA receptor